Osteoporosis is a chronic disease that primarily affects menopausal women and is characterised by low bone mass and increased risk of fractures. RANKL is the main mediator in bone resorption by inducing osteoclast generation. Recently, it was discovered that pharmaceutical inhibition of RANKL effectively prevents bone loss and fractures in osteoporotic patients, making RANKL the most specialised target against osteoporosis. The research group has recently generated mice that over-produce human RANKL using genetic engineering. The study analyses new genetic models of osteoporosis resulting from the overexpression of human RANKL. Specifically, we characterised two models of osteoporosis in detail, one with low expression of RANKL and mild osteoporosis and one with highly elevated levels of RANKL and characteristics of severe osteoporosis, such as trabecular bone loss, cortical porosity and reduced bone strength.
The administering of a commercial anti-osteoporotic drug in these models showed that bone loss was prevented, making them ideal models for the evaluation of new inhibitors against human RANKL in the preclinical level. The development of these first animal models of osteoporosis induced by overexpression of human RANKL will pave the way for the discovery of highly-specific novel drugs.
We use cookies to enhance your online experience, offer customized content according to your preferences, improve website’s performance and analyse the traffic.
By selecting “Accept all” you consent to the use of all cookies.
Cookies are small text files which are stored on your device when you visit our website. For further information on cookies, please read the website’s Terms of Use.
Categories of Cookies
Options
These cookies are absolutely necessary for the proper and secure operation of the website and they do not store information which identifies you. Therefore, they cannot be disabled and your consent for their use is not needed, in accordance with the current legislation.
These cookies collect information on how you use the website in order to improve your experience when visiting our website and collect statistical data, such as the website's traffic, the pages the users visit more often etc, by using Google Analytics tools.
These cookies are set and can only be read by the authorized provider of the website in order to personalize the content according to your preferences.
Targeting cookies store information regarding your personal interests and preferences. This type of cookies is not used to display advertisements or any other targeted commercial feature. Third parties may combine information you have provided to them or being collected by you on prior use of their services, for example when navigating to website’s pages embedded videos from our official channel in Youtube.
By selecting “Accept all” you consent to the use of all cookies.